Met Life Investment Management, LLC Avidity Biosciences, Inc. Transaction History
Met Life Investment Management, LLC
- $14.7 Billion
- Q1 2024
A detailed history of Met Life Investment Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 37,333 shares of RNA stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,333Holding current value
$1.53 Million% of portfolio
0.01%Shares
31 transactions
Others Institutions Holding RNA
# of Institutions
164Shares Held
71.6MCall Options Held
182KPut Options Held
55K-
Rtw Investments, LP New York, NY7.97MShares$326 Million3.26% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.43MShares$303 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.17MShares$252 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.83MShares$238 Million1.79% of portfolio
-
Cowen And Company, LLC5.63MShares$230 Million4.83% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.13B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...